Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Influenza, Human 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Sarcoma 1Recurrence 1Psoriasis 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Melanoma 1Medullary cystic kidney disease 1 1Lung Neoplasms 1Glioblastoma 1Epstein-Barr Virus Infections 1Diabetes Mellitus, Insulin-Dependent, 12 1Crohn Disease 1Condylomata Acuminata 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

upadacitinib 1Vaccines 1Saline Solution 1Melphalan 1Magnetic Resonance Spectroscopy 1Herpes Zoster Vaccine 1Collagenases 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Arthritis × Vaccines × Clear all
NCT02538341 2021-11-23

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

University of Alabama at Birmingham

Phase 2 Completed
617 enrolled 17 charts

Arthritis, Arthritis, Rheumatoid, Crohn Disease, Psoriasis, Spondylitis, Ankylosing, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡